Follow-up and Future Pregnancy Planning Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Follow-up and Future Pregnancy Planning. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Follow-up and Future Pregnancy Planning Indian Medical PG Question 1: Use of folic acid to prevent congenital malformations should be best initiated:
- A. During 1st trimester of pregnancy
- B. During 2nd trimester of pregnancy
- C. During 3rd trimester of pregnancy
- D. Before conception (Correct Answer)
Follow-up and Future Pregnancy Planning Explanation: ***Before conception***
- **Neural tube defects (NTDs)**, such as spina bifida and anencephaly, occur very early in pregnancy, often before a woman even knows she is pregnant.
- Adequate folate levels are crucial for **neural tube closure**, which happens between 21 and 28 days after conception. Therefore, supplementation needs to start before this period.
*During 1st trimester of pregnancy*
- While still helpful, initiating folic acid during the first trimester might be **too late** to prevent all NTDs.
- The critical period for neural tube formation has largely passed, meaning the **maximum preventive effect** may not be achieved.
*During 2nd trimester of pregnancy*
- This is **too late** for primary prevention of NTDs, as neural tube closure is completed in the first few weeks of gestation.
- At this stage, folic acid supplementation would primarily benefit the ongoing **fetal growth and development**, but not the prevention of NTDs.
*During 3rd trimester of pregnancy*
- This timing is **ineffective** for the prevention of congenital malformations like NTDs, which have already occurred or been avoided by this point.
- Folic acid at this stage primarily supports continued fetal growth and maternal health, but offers no additional benefit regarding **early developmental defects**.
Follow-up and Future Pregnancy Planning Indian Medical PG Question 2: Most accurate method to confirm viable intrauterine pregnancy at 6 weeks' gestation is
- A. USG fetal cardiac activity (Correct Answer)
- B. Clinical examination
- C. Urine HCG test
- D. Doppler ultrasound in specific clinical situations
Follow-up and Future Pregnancy Planning Explanation: **USG fetal cardiac activity**
- At 6 weeks' gestation, the presence of **fetal cardiac activity** on ultrasound is the definitive sign of a **viable intrauterine pregnancy**.
- This finding confirms both the presence of an embryo and its vital status, providing direct evidence of viability.
*Urine HCG test*
- A **urine HCG test** confirms the presence of pregnancy but does not provide information about its viability or location (intrauterine vs. ectopic).
- High HCG levels can be present even in non-viable or ectopic pregnancies.
*Clinical examination*
- A **clinical examination** may reveal signs consistent with pregnancy, such as an enlarged uterus, but it cannot definitively confirm **intrauterine location** or **fetal viability** at 6 weeks' gestation.
- These findings are supportive but not diagnostic of viability.
*Doppler ultrasound in specific clinical situations*
- Doppler ultrasound is typically used to assess **blood flow** to various structures and may be useful in later pregnancy for assessing fetal well-being or placental function.
- It is not the primary or most accurate method to confirm early **fetal cardiac activity** or viability at 6 weeks' gestation compared to standard grayscale ultrasound.
Follow-up and Future Pregnancy Planning Indian Medical PG Question 3: A pregnant lady delivers a healthy baby via normal delivery. What is the earliest time at which an intrauterine contraceptive device (IUCD) can be inserted?
- A. Within 48 hours (Correct Answer)
- B. After 6 weeks
- C. After 3 months
- D. After 1 month
Follow-up and Future Pregnancy Planning Explanation: ***Within 48 hours***
- **Immediate postpartum insertion** (within 48 hours of delivery) is considered safe and effective, with high client satisfaction and continuation rates.
- While there's a slightly higher risk of **expulsion** compared to later insertions, it provides immediate contraception for women who might not return for follow-up.
*After 6 weeks*
- This is a common time for postpartum check-ups and a traditional window for IUCD insertion, after the uterus has largely involuted.
- However, it is not the **earliest possible time**, as immediate postpartum insertion is also an option.
*After 3 months*
- Delaying IUCD insertion until three months postpartum is unnecessarily late if the woman desires contraception sooner.
- This longer delay could increase the risk of an **unintended pregnancy** during the interim.
*After 1 month*
- Insertion at one month postpartum is also a safe option, after early uterine involution.
- However, similar to the six-week option, it is not the **earliest possible time** for insertion.
Follow-up and Future Pregnancy Planning Indian Medical PG Question 4: Which of the following is an absolute indication for elective repeat caesarean section in a patient with previous caesarean delivery?
- A. Placenta accreta spectrum
- B. Previous classical incision (Correct Answer)
- C. Failed TOLAC (Trial of Labor After Cesarean)
- D. Uterine rupture/scar dehiscence
Follow-up and Future Pregnancy Planning Explanation: ***Previous classical incision***
- A **classical incision** (vertical uterine incision in the upper uterine segment) carries a **4-9% risk of uterine rupture** in subsequent pregnancies, compared to 0.5-1% with low transverse incisions.
- **VBAC (Vaginal Birth After Cesarean) is absolutely contraindicated** with a previous classical incision due to the high rupture risk.
- This is a **standing absolute indication** for elective repeat cesarean section at 36-37 weeks gestation.
- Other absolute indications include previous T-incision, J-incision, and previous uterine rupture.
*Uterine rupture/scar dehiscence*
- **Uterine rupture** is a catastrophic **intrapartum emergency** requiring immediate cesarean delivery.
- This is not a pre-existing "indication" but rather an **acute complication** that occurs during labor.
- Previous uterine rupture (not active rupture) would be an absolute indication for planned repeat C-section.
*Placenta accreta spectrum*
- This involves abnormal placental invasion and is strongly associated with previous C-sections.
- While it requires cesarean delivery with possible hysterectomy, it is a **complication of placental implantation**, not a direct indication based on the previous uterine incision type.
- It necessitates C-section but is not specific to the type of previous cesarean scar.
*Failed TOLAC (Trial of Labor After Cesarean)*
- A **failed TOLAC** means cesarean delivery is required because vaginal delivery could not be achieved.
- This is an **intrapartum decision** based on failure to progress or fetal compromise, not a pre-existing indication for planned repeat C-section.
Follow-up and Future Pregnancy Planning Indian Medical PG Question 5: A woman comes after 96 hours post coitus. Best contraceptive of choice is?
- A. Progesterone only pills
- B. OCP
- C. IUCD (Correct Answer)
- D. Mifepristone
Follow-up and Future Pregnancy Planning Explanation: ***IUCD***
- An **intrauterine contraceptive device (IUCD)** can be inserted up to **5 days (120 hours)** after unprotected intercourse or within 5 days of the earliest estimated ovulation.
- It is the **most effective form of emergency contraception**, offering approximately **99% efficacy**.
- Provides **immediate ongoing contraception** after insertion, making it the optimal choice at 96 hours post-coitus.
*Progesterone only pills*
- **Progesterone-only emergency contraceptive pills** (e.g., levonorgestrel) are most effective when taken within **72 hours (3 days)** of unprotected intercourse.
- At **96 hours**, their efficacy is **significantly reduced**, making them suboptimal compared to IUCD.
*OCP*
- **Combined oral contraceptive pills (OCPs)** used for emergency contraception (Yuzpe method) are less effective and have more side effects than other emergency contraceptive methods.
- Their effectiveness also significantly declines after **72 hours** post-coitus.
*Mifepristone*
- **Mifepristone** is an **anti-progestin** that can be used for emergency contraception within **120 hours (5 days)** of unprotected intercourse.
- While effective within this timeframe at **96 hours**, the **IUCD remains superior** due to its higher efficacy (>99% vs ~98%) and provision of ongoing contraception.
Follow-up and Future Pregnancy Planning Indian Medical PG Question 6: A woman dies from a heart disease six days after delivery. This would come under the category of :
- A. Direct maternal death
- B. Unclassified death
- C. Indirect maternal death (Correct Answer)
- D. Medical (non-maternal) death
Follow-up and Future Pregnancy Planning Explanation: ***Indirect maternal death***
- An **indirect maternal death** is defined as one resulting from a pre-existing disease or a disease that developed during pregnancy, which was not due to direct obstetric causes but was aggravated by the physiological effects of pregnancy.
- Heart disease in this context, especially when occurring six days postpartum, is often a pre-existing condition exacerbated by pregnancy-related cardiovascular demands, fitting this definition.
*Direct maternal death*
- **Direct maternal deaths** are those resulting from obstetric complications of the pregnant state, from interventions, omissions, incorrect treatment, or from a chain of events resulting from any of these.
- Examples include severe hemorrhage, pre-eclampsia/eclampsia, or obstructed labor, which are not described in this scenario.
*Unclassified death*
- An **unclassified death** is assigned when there is insufficient information to determine the cause of death as direct, indirect, or coincidental.
- In this case, the cause of death (heart disease) is known, making classification possible.
*Medical (non-maternal) death*
- This category usually refers to deaths from medical conditions **unrelated to or unaggravated by pregnancy**.
- While heart disease is a medical condition, its occurrence six days postpartum strongly suggests that the physiological changes of pregnancy played a significant role in its exacerbation or presentation, thereby classifying it as a maternal death rather than a coincidental non-maternal death.
Follow-up and Future Pregnancy Planning Indian Medical PG Question 7: The causes for subinvolution of uterus are the following except:
- A. Retained placental fragments
- B. Multiple pregnancy
- C. Established breast feeding (Correct Answer)
- D. Pelvic infection
Follow-up and Future Pregnancy Planning Explanation: ***Established breast feeding***
- **Breastfeeding** promotes the release of **oxytocin**, which aids in uterine contractions and thus helps the uterus return to its pre-pregnancy size and state, preventing subinvolution.
- Therefore, it is a protective factor against subinvolution, not a cause.
*Retained placental fragments*
- **Retained placental tissue** prevents the uterus from contracting effectively, leading to continued bleeding and an enlarged, soft uterus.
- This physical obstruction interferes with the normal process of **involution**.
*Multiple pregnancy*
- A uterus stretched significantly by a **multiple pregnancy** (e.g., twins or triplets) may have difficulty contracting efficiently after birth.
- The increased uterine size and distension can impair the myometrial fibers' ability to involute properly.
*Pelvic infection*
- **Infection** within the uterus (e.g., **endometritis**) can interfere with uterine contractions and tissue repair.
- The inflammatory process can delay or prevent the normal physiological reduction in uterine size, contributing to subinvolution.
Follow-up and Future Pregnancy Planning Indian Medical PG Question 8: As per the definition of the World Health Organization, 'late maternal death' is defined as the death of a woman from direct or indirect obstetric causes, after more than X days but less than one year after termination of pregnancy. Which one among the following is the correct value of X?
- A. 21
- B. 7
- C. 84
- D. 42 (Correct Answer)
Follow-up and Future Pregnancy Planning Explanation: ***Correct: 42***
- According to the **World Health Organization (WHO)**, **late maternal death** is defined as the death of a woman from direct or indirect obstetric causes occurring **more than 42 days** but less than one year after termination of pregnancy.
- This definition helps in categorizing and understanding the timeframe and causes of maternal mortality beyond the immediate postpartum period.
- The **42-day threshold** distinguishes between direct maternal deaths (within 42 days) and late maternal deaths (42 days to 1 year).
*Incorrect: 21*
- This value is not used in the WHO definition for the onset of late maternal death.
- The **42-day mark** is the internationally recognized threshold for distinguishing between the immediate postpartum period and late maternal complications.
*Incorrect: 7*
- Seven days is too short a period for a death to be classified as **"late maternal death"**; deaths within this timeframe fall under **direct maternal deaths** in the immediate postpartum period.
- This period is often associated with immediate postpartum complications such as **postpartum hemorrhage**, **eclampsia**, or **early-onset puerperal sepsis**.
*Incorrect: 84*
- While 84 days (12 weeks) is a significant period in postpartum recovery for some physiological changes, it is not the specific threshold used by the **WHO** to define the beginning of **late maternal death**.
- The international standard remains **42 days** (6 weeks) as the transition point between direct and late maternal deaths.
Follow-up and Future Pregnancy Planning Indian Medical PG Question 9: What is the type of placenta previa shown below?
- A. Type 1
- B. Type 2
- C. Type 3
- D. Type 4 (Correct Answer)
Follow-up and Future Pregnancy Planning Explanation: ***Type 4***
- Type 4 placenta previa, also known as **complete or central placenta previa**, occurs when the **placenta completely covers the internal cervical os**.
- This type necessitates a **cesarean section** delivery due to the complete obstruction of the birth canal.
*Type 1*
- Type 1 placenta previa, or **low-lying placenta**, means the placenta is in the lower uterine segment but **does not reach the cervical os**.
- It often resolves by term as the uterus grows, potentially allowing a **vaginal delivery**.
*Type 2*
- Type 2 placenta previa, or **marginal placenta previa**, indicates the placental edge **reaches the internal cervical os** but does not cover it.
- While a vaginal delivery might be possible, there's an increased risk of **hemorrhage**.
*Type 3*
- Type 3 placenta previa, or **partial placenta previa**, is where the placenta **partially covers the internal cervical os** but not completely.
- This type also typically requires a **cesarean section** due to the obstruction.
Follow-up and Future Pregnancy Planning Indian Medical PG Question 10: Consider the following regarding the use of Magnesium Sulphate:
1. Used as tocolytic
2. As neuroprotective agent
3. Used in management of postpartum eclampsia
Which of the statements given above are correct?
- A. 1 and 3 only
- B. 2 and 3 only
- C. 1 and 2 only
- D. 1, 2 and 3 (Correct Answer)
Follow-up and Future Pregnancy Planning Explanation: ***1, 2 and 3***
- **Magnesium sulfate** is a well-established **tocolytic agent**, used to delay preterm labor by relaxing the uterine smooth muscle.
- It is also utilized for its **neuroprotective effects** in preterm infants, reducing the risk of cerebral palsy and other neurological sequelae when administered to mothers at risk of preterm birth.
- Furthermore, magnesium sulfate is the **drug of choice** for the prevention and management of **eclampsia and pre-eclampsia**, which can occur both during pregnancy and in the postpartum period.
*1 and 3 only*
- This option correctly identifies the use of **magnesium sulfate** as a **tocolytic** and for **postpartum eclampsia**, but incorrectly omits its significant role as a **neuroprotective agent**.
- The neuroprotective effect, particularly in reducing the risk of cerebral palsy in preterm infants, is a crucial indication for magnesium sulfate use.
*2 and 3 only*
- This option correctly recognizes **magnesium sulfate's** application as a **neuroprotective agent** and in **postpartum eclampsia**, but overlooks its primary role as a **tocolytic** for preterm labor.
- Its ability to relax uterine contractions makes it a vital medication in managing threatened preterm delivery.
*1 and 2 only*
- This option accurately states the use of **magnesium sulfate** as a **tocolytic** and a **neuroprotective agent**, but fails to include its critical role in the management of **postpartum eclampsia**.
- Eclampsia, defined by seizures in a pre-eclamptic patient, is effectively prevented and treated with magnesium sulfate.
More Follow-up and Future Pregnancy Planning Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
